Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000133

Director sold 20,000 shares at an average $30.82 ($616,304)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessier-Lavigne Marc Director 2022-09-28 Sale −15,577 $30.74 $478,837 1,914,779 D
Tessier-Lavigne Marc Director 2022-09-28 Sale −4,423 $31.08 $137,467 1,910,356 D
Open-market sales · 20,000 sh · avg $30.82 · $616,304
Loading xslF345X03/wf-form4_166457103687475.xml…